South Cone Investments Limited Partnership
South Cone Investments Limited Partnership's purchase track record
How the stock did after each of South Cone Investments Limited Partnership's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 11/24/2023 | RANI | $10.58M | +64.7% | +120.9% | +16.4% |
| 5/8/2023 | RANI | $40K | -3.5% | -54.7% | +5.5% |
| 4/28/2023 | RANI | $20K | -9.2% | -58.4% | -1.3% |
| 4/18/2023 | RANI | $80K | -19.9% | -61.4% | +5.3% |
| 4/10/2023 | RANI | $54K | -19.1% | -66.1% | +5.5% |
| 3/30/2023 | RANI | $184K | -18.9% | -47.7% | +6.1% |
| 3/21/2023 | RANI | $39K | -26.0% | -50.9% | +11.0% |
| 3/13/2023 | RANI | $45K | -22.8% | -43.9% | +16.4% |
| 3/2/2023 | RANI | $67K | -32.0% | -39.6% | +13.2% |
| 2/22/2023 | RANI | $66K | -32.1% | -38.3% | +11.2% |
| 2/14/2023 | RANI | $221K | -20.3% | -16.4% | +7.3% |
| 12/28/2022 | RANI | $154K | -4.5% | -26.1% | +15.7% |
| 12/14/2022 | RANI | $209K | -27.5% | -42.4% | +9.4% |
| 12/13/2022 | FTCI | $114K | -10.3% | -2.6% | +8.7% |
| 12/6/2022 | RANI | $493K | -11.1% | -34.7% | +8.7% |
| 12/5/2022 | FTCI | $411K | +27.0% | +17.0% | +6.9% |
| 11/28/2022 | RANI | $272K | -20.8% | -48.0% | +6.1% |
| 11/18/2022 | RANI | $249K | -19.5% | -40.3% | +5.7% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 30, 2026
FTC Solar Partners with Linxon and Hitachi Energy for North America Projects. FTC Solar has announced a strategic collaboration with Linxon and Hitachi Energy to develop utility-scale renewable energy and grid infrastructure in North America. The agreement focuses on supplying solar and battery energy storage systems. This partnership aims to accelerate project execution and expand the company's presence in the region.
Transaction History
| RANI | ▼ Sell | Open Market | 4,000,000 | $11.1M | 10/21/2025 | View on chart |
| RANI | ▼ Sell | Open Market | 1,923,000 | $4.6M | 10/20/2025 | View on chart |
| RANI | ▼ Sell | Open Market | 3,305,622 | $8.4M | 10/15/2024 | View on chart |
| RANI | ▼ Sell | Open Market | 523,738 | $1.7M | 10/15/2024 | View on chart |
| RANI | ▲ Buy | Open Market | 5,265,165 | $10.6M | 11/24/2023 | View on chart |
| RANI | ▲ Buy | Open Market | 2,645 | $11K | 5/12/2023 | View on chart |
| RANI | ▲ Buy | Open Market | 2,610 | $10K | 5/11/2023 | View on chart |
| RANI | ▲ Buy | Open Market | 4,420 | $20K | 5/8/2023 | View on chart |
| RANI | ▲ Buy | Open Market | 2,040 | $10K | 5/3/2023 | View on chart |
| RANI | ▲ Buy | Open Market | 2,173 | $10K | 4/28/2023 | View on chart |
| RANI | ▲ Buy | Open Market | 4,423 | $20K | 4/25/2023 | View on chart |
| RANI | ▲ Buy | Open Market | 4,280 | $20K | 4/24/2023 | View on chart |
| RANI | ▲ Buy | Open Market | 4,100 | $20K | 4/21/2023 | View on chart |
| RANI | ▲ Buy | Open Market | 1,850 | $10K | 4/20/2023 | View on chart |
| RANI | ▲ Buy | Open Market | 1,850 | $10K | 4/18/2023 | View on chart |
| RANI | ▲ Buy | Open Market | 1,901 | $10K | 4/14/2023 | View on chart |
| RANI | ▲ Buy | Open Market | 890 | $5K | 4/13/2023 | View on chart |
| RANI | ▲ Buy | Open Market | 3,577 | $20K | 4/12/2023 | View on chart |
| RANI | ▲ Buy | Open Market | 1,765 | $10K | 4/11/2023 | View on chart |
| RANI | ▲ Buy | Open Market | 1,923 | $10K | 4/10/2023 | View on chart |
| RANI | ▲ Buy | Open Market | 7,551 | $39K | 4/6/2023 | View on chart |
| RANI | ▲ Buy | Open Market | 7,280 | $40K | 4/5/2023 | View on chart |
| RANI | ▲ Buy | Open Market | 4,416 | $24K | 4/4/2023 | View on chart |
| RANI | ▲ Buy | Open Market | 3,587 | $19K | 4/3/2023 | View on chart |
| RANI | ▲ Buy | Open Market | 751 | $4K | 3/31/2023 | View on chart |
| RANI | ▲ Buy | Open Market | 12,230 | $59K | 3/30/2023 | View on chart |
| RANI | ▲ Buy | Open Market | 3,510 | $19K | 3/28/2023 | View on chart |
| RANI | ▲ Buy | Open Market | 3,230 | $20K | 3/21/2023 | View on chart |
| RANI | ▲ Buy | Open Market | 532 | $3K | 3/20/2023 | View on chart |
| RANI | ▲ Buy | Open Market | 2,980 | $18K | 3/17/2023 | View on chart |
| RANI | ▲ Buy | Open Market | 1,325 | $8K | 3/16/2023 | View on chart |
| RANI | ▲ Buy | Open Market | 2,463 | $15K | 3/13/2023 | View on chart |
| RANI | ▲ Buy | Open Market | 3,730 | $24K | 3/9/2023 | View on chart |
| RANI | ▲ Buy | Open Market | 1,702 | $11K | 3/8/2023 | View on chart |
| RANI | ▲ Buy | Open Market | 1,100 | $7K | 3/6/2023 | View on chart |
| RANI | ▲ Buy | Open Market | 3,900 | $25K | 3/2/2023 | View on chart |
| RANI | ▲ Buy | Open Market | 711 | $4K | 2/28/2023 | View on chart |
| RANI | ▲ Buy | Open Market | 3,541 | $22K | 2/27/2023 | View on chart |
| RANI | ▲ Buy | Open Market | 5,451 | $33K | 2/24/2023 | View on chart |
| RANI | ▲ Buy | Open Market | 1,000 | $6K | 2/22/2023 | View on chart |
| RANI | ▲ Buy | Open Market | 3,080 | $18K | 2/21/2023 | View on chart |
| RANI | ▲ Buy | Open Market | 8,468 | $50K | 2/17/2023 | View on chart |
| RANI | ▲ Buy | Open Market | 9,500 | $52K | 2/16/2023 | View on chart |
| RANI | ▲ Buy | Open Market | 10,000 | $52K | 2/15/2023 | View on chart |
| RANI | ▲ Buy | Open Market | 9,250 | $49K | 2/14/2023 | View on chart |
| RANI | ▲ Buy | Open Market | 8,600 | $51K | 12/30/2022 | View on chart |
| RANI | ▲ Buy | Open Market | 8,600 | $51K | 12/29/2022 | View on chart |
| RANI | ▲ Buy | Open Market | 9,157 | $51K | 12/28/2022 | View on chart |
| RANI | ▲ Buy | Open Market | 6,900 | $51K | 12/19/2022 | View on chart |
| RANI | ▲ Buy | Open Market | 6,400 | $50K | 12/16/2022 | View on chart |
| RANI | ▲ Buy | Open Market | 6,500 | $52K | 12/15/2022 | View on chart |
| RANI | ▲ Buy | Open Market | 7,027 | $56K | 12/14/2022 | View on chart |
| FTCI | ▲ Buy | Open Market | 5,732 | $16K | 12/14/2022 | View on chart |
| RANI | ▲ Buy | Open Market | 12,050 | $99K | 12/13/2022 | View on chart |
| FTCI | ▲ Buy | Open Market | 36,230 | $98K | 12/13/2022 | View on chart |
| RANI | ▲ Buy | Open Market | 12,500 | $100K | 12/12/2022 | View on chart |
| FTCI | ▲ Buy | Open Market | 39,200 | $104K | 12/12/2022 | View on chart |
| RANI | ▲ Buy | Open Market | 12,345 | $99K | 12/9/2022 | View on chart |
| FTCI | ▲ Buy | Open Market | 2,800 | $7K | 12/9/2022 | View on chart |
| RANI | ▲ Buy | Open Market | 12,195 | $97K | 12/8/2022 | View on chart |
| FTCI | ▲ Buy | Open Market | 10,755 | $26K | 12/8/2022 | View on chart |
| RANI | ▲ Buy | Open Market | 600 | $5K | 12/7/2022 | View on chart |
| FTCI | ▲ Buy | Open Market | 41,666 | $92K | 12/7/2022 | View on chart |
| RANI | ▲ Buy | Open Market | 12,500 | $93K | 12/6/2022 | View on chart |
| FTCI | ▲ Buy | Open Market | 41,600 | $94K | 12/6/2022 | View on chart |
| RANI | ▲ Buy | Open Market | 12,195 | $97K | 12/5/2022 | View on chart |
| FTCI | ▲ Buy | Open Market | 36,859 | $88K | 12/5/2022 | View on chart |
| RANI | ▲ Buy | Open Market | 9,819 | $80K | 12/2/2022 | View on chart |
| RANI | ▲ Buy | Open Market | 202 | $2K | 12/1/2022 | View on chart |
| RANI | ▲ Buy | Open Market | 8,000 | $63K | 11/30/2022 | View on chart |
| RANI | ▲ Buy | Open Market | 3,720 | $30K | 11/28/2022 | View on chart |
| RANI | ▲ Buy | Open Market | 800 | $6K | 11/25/2022 | View on chart |
| RANI | ▲ Buy | Open Market | 3,396 | $27K | 11/23/2022 | View on chart |
| RANI | ▲ Buy | Open Market | 12,500 | $92K | 11/22/2022 | View on chart |
| RANI | ▲ Buy | Open Market | 3,200 | $25K | 11/21/2022 | View on chart |
| RANI | ▲ Buy | Open Market | 13,300 | $100K | 11/18/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
RANI joins FDA Emerging Technology Platform
Rani Therapeutics was added to the FDA’s Emerging Technology Platform, a program that highlights innovative medical technologies. The inclusion signals that the FDA sees potential in the company’s approach and may facilitate future regulatory interactions. This development comes as the stock is trading near its recent support level.
RANI joins FDA Emerging Technology Platform. Rani Therapeutics was added to the FDA’s Emerging Technology Platform, a program that highlights innovative medical technologies. The inclusion signals that the FDA sees potential in the company’s approach and may facilitate future regulatory interactions. This development comes as the stock is trading near its recent support level.